Skip to content

Clinical trials

Completed Observational Retinal Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Phase: Observational Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20131
20151
20161
20172
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beacon Therapeutics1
Editas Medicine, Inc.1
Foundation Fighting Blindness1
Glostrup University Hospital, Copenhagen1
Moorfields Eye Hospital NHS Foundation Trust1
Nanoscope Therapeutics Inc.1
National Cancer Institute (NCI)1
National Eye Institute (NEI)1
NightstaRx Ltd, a Biogen Company1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration10
Retinal Dystrophies3
Diabetic Retinopathy2
Eye Diseases2
Retinitis Pigmentosa2
Blindness1
Choroideremia1
Congenital Abnormalities1
Dermatitis1
Eye Abnormalities1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.